Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Buy
51
HRB Quote, Financials, Valuation and Earnings
Last price:
$52.49
Seasonality move
:
0.42%
Day range:
$51.38 - $52.58
52-week range:
$45.87 - $68.45
Dividend yield:
2.75%
P/E ratio:
14.46x
P/S ratio:
2.02x
P/B ratio:
97.55x
Volume:
11.8M
Avg. volume:
1.8M
1-year change:
8.88%
Market cap:
$7B
Revenue:
$3.6B
EPS (TTM):
$3.63
Analysts' Opinion
-
Consensus RatingH&R Block has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $62.33, H&R Block has an estimated upside of 18.75% from its current price of $52.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $49.00 representing 100% downside risk from its current price of $52.49.
Fair Value
-
According to the consensus of 2 analysts, H&R Block has 18.75% upside to fair value with a price target of $62.33 per share.
HRB vs. S&P 500
-
Over the past 5 trading days, H&R Block has overperformed the S&P 500 by 3.97% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
H&R Block does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
H&R Block revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter H&R Block reported revenues of $179.1M.
Earnings Growth
-
H&R Block earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter H&R Block reported earnings per share of -$1.80.
Enterprise value:
9B
EV / Invested capital:
6.38x
Price / LTM sales:
2.02x
EV / EBIT:
11.34x
EV / Revenue:
2.48x
PEG ratio (5yr expected):
0.79x
EV / Free cash flow:
13.08x
Price / Operating cash flow:
10.65x
Enterprise value / EBITDA:
9.86x
Gross Profit (TTM):
$1.6B
Return On Assets:
18.4%
Net Income Margin (TTM):
14.71%
Return On Equity:
--
Return On Invested Capital:
38.08%
Operating Margin:
-163.79%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.5B | $3.5B | $3.6B | $179.1M | $179.1M | |
| Gross Profit | $1.5B | $1.6B | $1.6B | -$120.7M | -$135.1M | |
| Operating Income | $704.7M | $767.3M | $757.4M | -$267.4M | -$293.3M | |
| EBITDA | $850.3M | $935.2M | $911.9M | -$231.4M | -$261.4M | |
| Diluted EPS | $2.90 | $3.63 | $3.63 | -$1.33 | -$1.80 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $1.2B | $775.9M | $898.9M | $777.4M | |
| Total Assets | -- | $3.1B | $2.6B | $2.8B | $2.7B | |
| Current Liabilities | -- | $1.2B | $645.8M | $745.6M | $1.1B | |
| Total Liabilities | -- | $3.5B | $3.2B | $3.5B | $3.6B | |
| Total Equity | -- | -$372.7M | -$643.5M | -$772.7M | -$872.5M | |
| Total Debt | -- | $2.3B | $2.1B | $2.3B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $941.7M | $660.1M | $767.4M | -$607.2M | -$567.1M | |
| Cash From Investing | -$118.2M | -$73.3M | -$110.3M | -$47.2M | -$61.1M | |
| Cash From Financing | -$978.7M | -$544.4M | -$641.2M | $530.6M | $543M | |
| Free Cash Flow | $877.6M | $599.2M | $687.3M | -$627M | -$597.4M | |
HRB
Sector
Market Cap
$7B
$414.9M
Price % of 52-Week High
76.68%
69.93%
Dividend Yield
2.75%
0%
Shareholder Yield
6.57%
3.88%
1-Year Price Total Return
8.88%
-15.73%
Beta (5-Year)
0.651
0.943
Dividend yield:
2.75%
Annualized payout:
$1.28
Payout ratio:
35.09%
Growth streak:
4 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$51.54
200-day SMA
Sell
Level
$56.86
Bollinger Bands (100)
Sell
Level
52.43 - 58.59
Chaikin Money Flow
Buy
Level
450.5M
20-day SMA
Sell
Level
$52.65
Relative Strength Index (RSI14)
Sell
Level
48.60
ADX Line
Sell
Level
13.81
Williams %R
Neutral
Level
-58.2183
50-day SMA
Sell
Level
$53.36
MACD (12, 26)
Sell
Level
-0.38
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
486.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.5395)
Sell
CA Score
(Annual)
Level (-1.0145)
Buy
Beneish M-Score
(Annual)
Level (-3.5194)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (1.9781)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.
Stock Forecast FAQ
In the current month, HRB has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HRB average analyst price target in the past 3 months is $62.33.
-
Where Will H&R Block Stock Be In 1 Year?
According to analysts, the consensus estimate is that H&R Block share price will rise to $62.33 per share over the next 12 months.
-
What Do Analysts Say About H&R Block?
Analysts are divided on their view about H&R Block share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that H&R Block is a Sell and believe this share price will drop from its current level to $49.00.
-
What Is H&R Block's Price Target?
The price target for H&R Block over the next 1-year time period is forecast to be $62.33 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HRB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for H&R Block is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of HRB?
You can purchase shares of H&R Block via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase H&R Block shares.
-
What Is The H&R Block Share Price Today?
H&R Block was last trading at $52.49 per share. This represents the most recent stock quote for H&R Block. Yesterday, H&R Block closed at $52.49 per share.
-
How To Buy H&R Block Stock Online?
In order to purchase H&R Block stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is up 0.63% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 2.61% over the past day.
Buy
61
ALNY alert for Mar 24
Alnylam Pharmaceuticals [ALNY] is up 3.41% over the past day.
